The skinny on obesity and plasma cell myeloma: a review of the literature. (Q38211267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

The skinny on obesity and plasma cell myeloma: a review of the literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

K R Carson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

M H Tomasson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

12 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

1009-1015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2014.71

18 March 2020

exact match

0 references

cites work

Prevalence of overweight and obesity in the United States, 1999-2004

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Body-Mass Index and Mortality among 1.46 Million White Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Body-mass index and mortality in Korean men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Body mass index, physical activity, and risk of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

The anti-inflammatory effect of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Vegetable and fruit intake and non-Hodgkin lymphoma survival in Connecticut women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Physical Activity and Survival After Breast Cancer Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Anthropometric characteristics and risk of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Association of anthropometric characteristics with the risk of malignant lymphoma and plasma cell myeloma in a Japanese population: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Anthropometric characteristics and multiple myeloma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Relation of body mass index to cancer risk in 362,552 Swedish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Overweight, obesity and risk of haematological malignancies: a cohort study of Swedish and Finnish twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Measured body mass index in adolescence and the incidence of colorectal cancer in a cohort of 1.1 million males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Risks and consequences of childhood and adolescent obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Body fat distribution and risk of cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Diet and risk of multiple myeloma in Connecticut women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Physical activity and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Regular recreational physical activity and risk of hematologic malignancies: results from the prospective VITamins And lifestyle (VITAL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Physical activity and risk of lymphoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Changes in weight, waist circumference and compensatory responses with different doses of exercise among sedentary, overweight postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Is exercise effective for weight loss with ad libitum diet? Energy balance, compensation, and gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Adiponectin: more than just another fat cell hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

The role of the adipocyte hormone adiponectin in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

A prospective study of circulating adipokine levels and risk of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

The role of adiponectin in cancer: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Adiponectin in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Narrative review: the role of leptin in human physiology: emerging clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Leptin influences cellular differentiation and progression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

The insulin-like growth factor system and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Insulin-like growth factor receptor inhibitors: baby or the bathwater?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

The major inflammatory mediator interleukin-6 and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

A comparison of allografting with autografting for newly diagnosed myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Umbilical cord blood transplantation: the first 25 years and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Influence of body mass index on survival in veterans with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Obesity. Halting the obesity epidemic: a public health policy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Insurance coverage for weight loss: overweight adults' views

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Comparative effectiveness of weight-loss interventions in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Cost-effectiveness of bariatric surgery: should it be universally available?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Use of metformin and survival of diabetic women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Changes in intake of fruits and vegetables in relation to risk of obesity and weight gain among middle-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Obesity and cancer: Pathophysiological and biological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.71

Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma

21 January 2018

1 reference

12 December 2020

A formula to estimate the approximate surface area if height and weight be known. 1916.

1 reference

12 December 2020

Metformin is associated with improved survival in endometrial cancer

1 reference

12 December 2020

Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: a case-control study

1 reference

12 December 2020

Exercise, Inflammation, and Innate Immunity

1 reference

12 December 2020

Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics.

1 reference

12 December 2020

Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma

1 reference

12 December 2020

Differential effects of body fatness and body fat distribution on risk factor for cardiovascular disease in women. Impact of weight loss

1 reference

12 December 2020

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor

1 reference

12 December 2020

Hormonal and growth factor responses to heavy resistance exercise protocols

1 reference

12 December 2020

Interleukin-6 prevents dexamethasone-induced myeloma cell death.

1 reference

12 December 2020

Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans

1 reference

12 December 2020

Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study

1 reference

12 December 2020

Risk factors for multiple myeloma: evidence from the Japan Collaborative Cohort (JACC) study

1 reference

12 December 2020

Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells

1 reference

12 December 2020

Self-reported weight and height

1 reference

12 December 2020

Exercise and older patients: prescribing guidelines

1 reference

12 December 2020

Possible association between obesity and posttransplantation complications including infectious diseases and acute graft-versus-host disease

1 reference

12 December 2020

Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines.

1 reference

12 December 2020

Dietary fish intake and risk of leukaemia, multiple myeloma, and non-Hodgkin lymphoma

1 reference

12 December 2020

Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.

1 reference

12 December 2020

Prevalence of monoclonal gammopathy of undetermined significance

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2014.71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

18 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820216%20AND%20SRC:MED&resulttype=core&format=json